Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: Secondary analysis of a 12-country randomised placebocontrolled trial using randomisationbased efficacy estimators

David Gillespie*, Kerenza Hood, Daniel Farewell, Christopher C. Butler, Theo Verheij, Herman Goossens, Beth Stuart, Mark Mullee, Paul Little

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Adherence-adjusted estimates of benefits and harms from treatment with amoxicillin for LRTI: Secondary analysis of a 12-country randomised placebocontrolled trial using randomisationbased efficacy estimators'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science